Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
139.9 USD | +0.04% | +2.50% | +5.79% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.79% | 14.07B | |
-1.97% | 103B | |
+6.97% | 101B | |
+4.40% | 23.07B | |
-11.95% | 22.23B | |
-4.36% | 18.05B | |
-39.98% | 17.18B | |
-10.74% | 16.94B | |
+37.79% | 12.35B | |
-23.48% | 8.36B |
- Stock Market
- Equities
- NBIX Stock
- News Neurocrine Biosciences, Inc.
- Neurocrine Biosciences Says Valbenazine Cuts Chorea in Huntington Disease in Late-Stage Trial -- Stock Up 4% After-Hours